Acetazolamide in Acute Decompensated Heart Failure with Volume Overload
Wilfried Müllens(Ziekenhuis Oost-Limburg), Matthias Dupont(Inserm), Katrien Tartaglia(Inserm), Walter Droogné(Inserm), Frank Ruschitzka(Kantonsspital St. Gallen), Gerasimos Filippatos(National and Kapodistrian University of Athens), Pieter Martens(Ziekenhuis Oost-Limburg), Petra Nijst(Inserm), Pierre Troisfontaines(Inserm), W. Smolders(Inserm), David Derthoo(Inserm), Liesbeth Bruckers(Inserm), Frederik H. Verbrugge(Vrije Universiteit Brussel), Fabien Chenot(Inserm), Kevin Damman(University Medical Center Groningen), Jeroen Dauw(Onze Lieve Vrouwziekenhuis Hospital), Johan Lassus(University of Helsinki), Philippe Blouard(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Riet Dierckx(Inserm), Samer Moubayed(Inserm), Jozine M. ter Maaten(University Medical Center Groningen), Evelyne Meekers(Ziekenhuis Oost-Limburg)
Cited by 553
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k